SCHEMBL2987763

SCHEMBL2987763

CC/C=C\C[C@@H](/C=C/C=C\CCCCCCCC(=O)O)OO

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
FASN P49327 1/20 0.54
PPARG P37231 3/20 0.53
GPR132 Q9UNW8 1/20 0.53
ALDH1A1 P00352 3/20 0.52
F7 P08709 2/20 0.52
F3 P13726 2/20 0.52
MAPT P10636 2/20 0.52
CYP19A1 P11511 2/20 0.52
OXER1 Q8TDS5 2/20 0.52
KDM4E B2RXH2 2/20 0.52
FFAR1 O14842 1/20 0.52
NR1I2 O75469 1/20 0.52
LMNA P02545 1/20 0.52
PLA2G1B P04054 1/20 0.52
CYP3A4 P08684 1/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
PTGS1 P23219 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830943 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL29896669 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL4612000 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL4611998 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL5696154 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL2987766 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL7215589 1.00 MEN1 (0.69) MEN1KMT2AFASNPPARGGPR132
SCHEMBL17701362 0.96 MEN1 (0.65) MEN1KMT2AFASNPPARGGPR132
SCHEMBL30468654 0.95 MEN1 (0.65) MEN1KMT2AFASNPPARGGPR132
SCHEMBL23628381 0.93 ALDH1A1 (0.62) MEN1KMT2APPARGALDH1A1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022074176-A1 METHOD FOR ELICITING AT LEAST ONE DEFENSE MECHANISM IN PLANTS AGAINST PLANT PESTS AND PLANT DISEASES Université de Liège (BE) 2022-04-14 WO claimed
EP-1268819-B1 MUSKMELON (CUCUMIS MELO) HYDROPEROXIDE LYASE AND USES THEREOF FIRMENICH & CIE (CH) 2006-06-07 EP claimed
US-20250311723-A1 METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS IMPELLO BIOSCIENCES, INC. 2025-10-09 US disclosed
US-12297477-B2 Process for making flavor and fragrant compounds FIRMENICH SA (CH) 2025-05-13 US disclosed
CN-119924453-A Fermented low-GI purple potato noodles and preparation method thereof 上海交通大学 2025-05-06 CN disclosed
CN-118480580-A Method for synthesizing jasmone by catalyzing multienzyme cascade reaction 江南大学 2024-08-13 CN disclosed
US-20240191261-A1 PROCESS FOR MAKING FLAVOR AND FRAGRANT COMPOUNDS FIRMENICH SA (CH) 2024-06-13 US disclosed
CN-117660498-A Application of phospholipase A1 gene DAD1 in creating male sterile line of rape 浙江大学 2024-03-08 CN disclosed
CN-116497044-A AOS1 gene for regulating and controlling daytime flowering time of rice and application thereof 华南农业大学 2023-07-28 CN disclosed
CN-116497044-A AOS1 gene for regulating and controlling daytime flowering time of rice and application thereof 华南农业大学 2023-07-28 CN disclosed
US-20230200385-A1 METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS IMPELLO BIOSCIENCES, INC. 2023-06-29 US disclosed
US-20160145638-A1 MUTATED ALLENE OXIDE SYNTHASE 2 (AOS2) GENES CIBUS US LLC (US) 2016-05-26 US disclosed
US-7786348-B2 Methods for producing pathogen-resistant plants with allene oxide synthase and divinyl ether synthase, and the amino acid and nucleotide sequences thereof BASF PLANT SCIENCE GMBH (DE) 2010-08-31 US disclosed
US-20090144856-A1 Methods for producing pathogen-resistant plants with allene oxide synthase and divinyl ether synthase, and the amino acid and nucleotide sequences thereof BASF PLANT SCIENCE GMBH (DE) 2009-06-04 US disclosed
US-7321025-B2 Isolated oxide synthase and divinyl ether synthase and uses thereof BASF PLANT SCIENCE GMBH (DE) 2008-01-22 US disclosed
EP-1621631-A1 Method for the production of C6 and/or C9 aldehydes and alcohols in plants by 9/13 divinyl ether synthase Georg-August-Universität Göttingen (DE) 2006-02-01 EP disclosed
EP-1409662-B1 ALLENE OXIDE SYNTHASE AND DIVINYL ETHER SYNTHASE FROM THE CYP74-ENZYME FAMILY ISOLATED OUT OF PHYSCOMITRELLA PATENS, THE NUCLEOTIDE SEQUENCES THAT CODE THESE SYNTHASES, AND METHOD FOR PRODUCING PATHOGEN-RESISTANT PLANTS BASF PLANT SCIENCE GMBH (DE) 2006-02-01 EP disclosed
US-20050223437-A1 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants BASF PLANT SCIENCE GMBH (DE) 2005-10-06 US disclosed
US-20040010822-A1 Hydroperoxyde lyases E.I. DU PONT DE NEMOURS AND COMPANY 2004-01-15 US disclosed
WO-2003006647-A9 ALLENE OXIDE SYNTHASE AND DIVINYL ETHER SYNTHASE FROM THE CYP74-ENZYME FAMILY ISOLATED OUT OF PHYSCOMITRELLA PATENS, THE NUCLEOTIDE SEQUENCES THAT CODE THESE SYNTHASES, AND METHOD FOR PRODUCING PATHOGEN-RESISTANT PLANTS BASF PLANT SCIENCE GMBH (DE) 2003-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250311723-A1 METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS ERG28, AHCY, BROX MEN1 2970/4885KMT2A 1306/4885FASN 80/4885
US-20230200385-A1 METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS ERG28, AHCY, BROX MEN1 2970/4885KMT2A 1306/4885FASN 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.